ClinicalTrials.Veeva

Menu

Normal Hemostasis Values in Premature Infants (PRHEMO)

U

University Hospital, Strasbourg, France

Status

Enrolling

Conditions

Premature Infant, Hemostasis

Study type

Observational

Funder types

Other

Identifiers

NCT07349251
9948 (Other Identifier)

Details and patient eligibility

About

This study aims to retrospectively determine, in a large cohort of apparently healthy children born before 37 weeks of gestation, the expected values of certain hemostasis parameters from birth to 18 months (when they start walking), and to determine whether or not they differ from those of full-term infants.

Enrollment

1,000 estimated patients

Sex

All

Ages

Under 18 months old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients aged 18 months or younger for whom a sample was sent to the Hematology Laboratory at Strasbourg University Hospital for measurement of a hemostasis parameter

Exclusion criteria

  • Patients with incomplete data
  • Patients with a congenital hemostasis disorder (hemophilia A or B, von Willebrand disease), a coagulopathy, or hepatocellular insufficiency

Trial contacts and locations

1

Loading...

Central trial contact

Agathe HERB, PharmD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems